SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Donald Trump's State of the Union address is driving immediate conversation around DJT, generating intensely polarized reactions with supporters praising his "epic" speech while detractors label it a "clown show" "full of lies." Community discussions actively center on his policy claims regarding tariffs, immigration, and the economy, alongside renewed chatter on Epstein-related allegations.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending following its CEO's significant presentation at a major cancer summit outlining breakthroughs in 'chemo-free' treatments and recent international regulatory approvals for its ANKTIVA therapy. The community is actively discussing the stock's "unstoppable" scientific progress and the potential for a substantial short squeeze fueled by high short interest.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending due to upcoming earnings and intense debate surrounding the CLARITY Act's impact on stablecoin yields, with bulls highlighting growing institutional adoption and USDC's foundational role while bears cite regulatory uncertainty, past insider selling, and its price correlation to broader crypto market volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical ($DRTS) is trending as the community anticipates imminent Japanese marketing approval for its Alpha DaRT cancer treatment, further validated by successful glioblastoma patient outcomes and growing institutional interest, positioning the company for significant global commercial expansion.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending as its board evaluates Paramount Skydance's revised $31/share all-cash offerwhich includes a ticking fee and covers the $2.8B Netflix breakup feeto determine if it's superior to Netflix's $27.75/share bid, fueling community debate over shareholder value, regulatory risks, and the optimal path for the media giant.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as Warner Bros. Discovery re-evaluates its acquisition offers, granting a limited waiver to re-engage with PSKY following its revised, all-cash bid including substantial regulatory breakup and ticking fees. The community is actively discussing PSKY's offer as potentially superior against Netflix's, while also weighing concerns about the massive debt PSKY would incur if successful.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst an intensified bidding war for Warner Bros. Discovery, as Paramount Skydance's revised offer gives Netflix a limited window to respond. The community is sharply divided on whether Netflix will walk away to collect a $2.8 billion breakup fee and potentially boost its stock, or if it will raise its bid and risk overpaying, further complicated by political pressure and antitrust concerns.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

Cava Group is trending following its earnings report, which showcased robust revenue growth and restaurant expansion, pushing its annual revenue past $1 billion. The community is actively debating the company's valuation and decelerating same-store sales against its ambitious growth plans and strong digital performance.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is a top trend as the market eagerly anticipates its upcoming earnings, with community discussion intensely focused on whether the results will propel the broader AI sector and major indices or lead to a "sell the news" reaction, amplified by recent headlines about US-China chip export restrictions.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is trending amid surging Chinese lithium futures and a 74% price target hike from UBS, as the community actively discusses insider buying and the company's sale of high-purity lithium fines at premium prices, anticipating a broader "Lithium Super Cycle" driven by EV and energy storage demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company’s EBITDA forecast of around $110 million to $140 million falls short of its FY2025 EBITDA of $151.2 million.</li><li>Evolent’s Q4 revenue fell 27% to $468.7 million, but beat estimates of $467.5 million, according to Fiscal.ai data.</li><li>Keybanc sees Evolent’s debt leverage rising to about seven times before potentially moderating.</li></ul>Shares of Evolent Health (EVH) fell more than 5% in pre-market trading on Wednesday, following a bearish brokerage action after the company announced lower earnings guidance alongside its fourth-quarter results.If the pre-market levels hold after the opening bell, <a href="https://stocktwits.com/symbol/EVH">EVH stock</a> would fall to an all-time low. This adds to the heavy selling pressure over the past month, during which the shares have slumped 31%.The company also generated significant retail buzz. According to Stocktwits data, message volume on the platform increased by 1,850% over the past 24 hours and by 1,200% over the past seven days.<h2 class="st-heading-2">Q4 Revenue Beats Estimates Despite 27% Drop</h2>Evolent’s fourth-quarter revenue declined 27% to $468.7 million, but came in just over Wall Street’s estimates of $467.5 million, according to Fiscal.ai data. On an adjusted basis, the company reported earnings of $0.08 per share, beating consensus estimates of $0.05 per share.Evolent forecasts full-year 2026 revenue to be in the range of $2.4 billion to $2.6 billion, above the $1.88 billion revenue it reported in FY 2025. However, its adjusted earnings before interest, tax, depreciation and amortization (EBITDA) forecast of around $110 million to $140 million falls short of its FY2025 EBITDA of $151.2 million.“While the addition of $900 million in new Performance Suite revenue in 2026, as well as the impact of significant health plan customer membership decreases in their Exchange products, create an impact on Adjusted EBITDA in the first half of the year, we believe our year-end 2026 margins should quickly step-up as new contract reserving effects ease throughout the year and our operating cost reduction plan ramps up across 2026,” CEO Seth Blackley said.<h2 class="st-heading-2">Keybanc Flags Lack Of Visibility In EBITDA Recovery&nbsp;</h2>KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’ without adding a price target, according to The Fly. Although the firm described Evolent’s Q4 results as ‘solid’, KeyBanc had expected the company’s debt leverage to begin easing in early 2026. Instead, the brokerage sees leverage rising to about seven times before potentially moderating later in 2026.Keybanc also added that the downgrade reflects “limited visibility into a meaningful EBITDA recovery in the near term.”“While this increase in revenue creates a powerful foundation for EBITDA acceleration, it also creates a temporary headwind in 2026 due to our reserving methodologies and the timing of implementation of the new contracts. Second, Specialty TNS 2026 performance is experiencing a significant headwind from exchange membership declines consistent with the entire industry,” CFO Mario Ramos said in a call with analysts.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the pre-market fall, retail sentiment turned ‘neutral’ from ‘bearish’ a day earlier, amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/EVH_jpg_11849304d8.webp" alt="EVH.jpg">One user said the stock’s decline doesn’t reflect its fair value.<stembedurl>https://stocktwits.com/BPler/message/645782444</stembedurl>Another user does not expect the stock price to drop any further.<stembedurl>https://stocktwits.com/PHILMYWALLET/message/645787843</stembedurl>The stock has been in an extended downtrend, declining more than 34% so far in 2026 and over 75% in the past year.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-sp500-futures-subdued-nvda-nflx-wbd-unh-lcid-wulf-stocks-to-watch/cZRUzKuR46j">Nasdaq, S&amp;P 500 Futures Subdued Ahead Of Nvidia Earnings: Why WBD, NFLX, UNH, LCID, WULF Are On Traders' Radar Today</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Evolent Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious 

KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’, citing a lack of visibility in near-term EBITDA recovery.

Equity

<ul class="summary-bullets"><li>The contract encompasses a broad range of work areas that allows for the rapid delivery of innovative capabilities to the warfighter with increased speed and agility, it said in a statement.&nbsp;</li><li>Participation in the SHIELD IDIQ contract provides a contractual framework through which IonQ may compete for future task orders, subject to agency requirements and competitive selection processes.&nbsp;</li><li>IonQ has a history of supporting U.S. government research and development initiatives, including work with agencies such as DARPA, the U.S. Air Force Research Laboratory.&nbsp;</li></ul>IonQ on Monday announced that it won a contract from the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program, which has a ceiling&nbsp;worth up to $151 billion.At the time of writing stock was up 2%.&nbsp;The contract encompasses a broad range of work areas that allows for the rapid delivery of innovative capabilities to the warfighter with increased speed and agility, it said in a statement.&nbsp;IonQ has a history of supporting U.S. government research and development initiatives, including work with agencies such as DARPA, the U.S. Air Force Research Laboratory, and organizations across the national security community.<h2 class="st-heading-2">SHIELD IDIQ</h2>IonQ is among more than 2,400 companies eligible to compete for future task orders issued under the SHIELD IDIQ contract framework.Participation in the SHIELD IDIQ contract provides a contractual framework through which IonQ may compete for future task orders, subject to agency requirements and competitive selection processes.&nbsp;“IonQ brings together a broad set of quantum technologies and supporting capabilities that reflect years of investment across computing, networking, sensing, and security,” said Niccolo de Masi, Chairman and CEO of IonQ. “We look forward to continuing our work with U.S. government partners across a range of research, development, and innovation programs.”<h2 class="st-heading-2">Other Firms In The Program</h2>AST SpaceMobile Inc. (ASTS) in January announced that it has been awarded a contract for the Missile Defense Agency SHIELD program.AST SpaceMobile was selected as a lead contractor, granting the company the opportunity to compete for a variety of upcoming projects. These projects could encompass research, development, engineering, prototyping, and overseeing vital systems for the Missile Defense Agency that support U.S. national security interests.<h2 class="st-heading-2">How Did Stocktwits’ Users React?</h2>Retail sentiment around IONQ trended in ‘bearish’ territory amid ‘low’ message volume.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, a person holds a smartphone displaying the logo of IONQ Inc.

Why Is IonQ Stock Surging After-Hours?

IonQ is among more than 2,400 companies eligible to compete for future task orders issued under the SHIELD IDIQ contract framework.

<ul class="summary-bullets"><li>Domino’s reported a 3.7% year-on-year increase in same-store sales in the U.S. in Q4, while international same-store sales rose 0.7% YoY.</li><li>The firm estimated that it will “meaningfully” increase its market share in the U.S. QSR pizza category in 2026, which is itself continuing to grow.</li><li>Its topline growth during the quarter was driven primarily by higher supply chain revenues, franchise advertising in the U.S., and franchise royalties and fees, the company added.</li></ul>Domino’s Pizza Inc. (DPZ) shares popped nearly 6% in Monday’s pre-market trade after the company’s fourth-quarter (Q4) results showed the company gained market share in the U.S. thanks to its “Hungry for More” strategy.Domino’s reported earnings per share (EPS) of $5.35 on revenue of $1.54 billion, compared to estimates of an EPS of $5.38 on revenue of $1.52 billion, according to Stocktwits data.The company said that its market share in the U.S. increased by another point, keeping it ahead of the Quick Service Restaurant (QSR) pizza category. Domino’s also posted its 32nd consecutive year of same-store sales growth internationally.“In 2025, we demonstrated that when we execute our Hungry for MORE strategy, it delivers MORE sales, MORE stores, and MORE profits," said Domino's CEO Russell Weiner.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/DPZ">Domino’s Pizza</a> trended in the ‘extremely bullish’ territory at the time of writing.<h2 class="st-heading-2">Domino’s Optimistic Looking Ahead</h2>The company said in its announcement that it is optimistic as it looks ahead to 2026, estimating it will “meaningfully” increase its market share in the U.S. QSR pizza category, which is itself continuing to grow.“Our value and scale advantages will remain a differentiator, while our new brand campaign and e-commerce site will drive deliciousness and improved experiences,” the company said.Domino’s reported a 3.7% year-on-year (YoY) increase in same-store sales in the U.S. in Q4, while international same-store sales rose 0.7% YoY.The company said that its strong Q4 flowed through to increased profits for franchisees. It announced a 15% increase in its quarterly dividend to $1.99 per share, payable to shareholders of record as of March 13, 2026, to be paid on March 30, 2026.<h2 class="st-heading-2">What Drove Domino’s Revenue Growth In Q4?</h2>Domino’s stated that its topline growth of 6.4% YoY during the quarter was driven primarily by higher supply chain revenues, franchise advertising in the U.S., and franchise royalties, as well as fees.Supply chain revenue growth was boosted by higher order volumes and Domino’s raising food basket pricing for stores.However, the company also reported a decline in gross margins for company-owned stores, which fell 5.4% YoY in Q4. This was a result of higher insurance costs and higher labor rates, Domino’s said.<a href="https://stocktwits.com/symbol/DPZ">DPZ stock</a> is down 8% year-to-date and 18% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-replicate-most-tariffs-after-supreme-court-ruling-goldman-sachs/cZRNfSqR4xV">Trump Administration Can Replicate Most Of The Tariffs, Says Goldman Sachs Following Supreme Court Rebuke: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

People sit outside a Domino's outlet in Penzance, England. (Photo by Matt Cardy/Getty Images)

DPZ Stock Pops Pre-Market As Domino’s ‘Hungry For More’ Strategy Drives 32nd Straight Year Of International Same-Store Sales Growth

The company said that its market share in the U.S. increased by another point, keeping it ahead of the Quick Service Restaurant pizza category.

<ul class="summary-bullets"><li>In its bid to add more mortgage options to its platform, Opendoor acquired homebuyer.com, a mortgage data platform, in Dec. last year.&nbsp;</li><li>OPEN’s CEO said that the company shipped its latest feature late Thursday.&nbsp;</li><li>The real estate digital platform on Thursday posted revenue for the fourth-quarter (Q4) of $736 million, much above street expectations of $591.75 million, as per data from Fiscal.ai.</li></ul>OpenDoor's (<a href="https://stocktwits.com/symbol/OPEN">OPEN</a>) Chief Executive Officer Kaz Nejatian in an exclusive interview to Stocktwits on Friday hinted that the company's mortgage product is in beta phase as the company pushes to enable itself to issue its own mortgage on homes it sells, helping cut out middlemen.“I left the earnings call and came to the office and started working on our product because we actually shipped a new feature late last night around 11 p.m. So I was up a little late shipping,” Nejatian told Stocktwits’ in an <a href="https://stocktwits.com/symbol/OPEN/event/f9cbb7c3-0777-4d00-8179-249bbbf2628b">interview</a>.&nbsp;In its bid to add more mortgage options to its platform, Opendoor acquired homebuyer.com, a mortgage data platform, in Dec. last year. The deal fits OPEN’s CEO Kaz’s AI-pilled vision of using data to eliminate ‘toilful work’ like manual paperwork.<h2 class="st-heading-2">Critical Of Fed</h2>Nejatian criticized the U.S. Federal Reserve for maintaining the interest rates at the level they are.&nbsp;“I think the Fed is being deeply irresponsible these days with maintaining these interest levels,” he told Stocktwits.&nbsp;“Trueflation, which is a much better measure of inflation than CPI, truflation has been sub 1 % basically the entire year. The Fed is asking people to believe that Bureau of Labor Statistics’ (BLS) data is a more reliable source for inflation and what's happening to the economy than truflation. And no one believes that. There's no one who invests their own money who would look at BLS data,” he added.&nbsp;The Federal Reserve kept the benchmark interest unchanged at 3.5%-3.75% in its January meeting. The latest Federal Open Market Committee’s (FOMC) minutes released by the Fed earlier this week revealed that the central bank might hike the interest rates if inflation does not come down to its targeted range.&nbsp;“I think it is highly irresponsible to have artificially elevated interest rates at this time. And I think they need to do something because this is just like, it's very odd,” Nejatian further added.&nbsp;<h2 class="st-heading-2">Q4 Earnings</h2>The real estate digital platform posted revenue for the fourth-quarter (Q4) of $736 million, much above street expectations of $591.75 million, as per data from Fiscal.ai. Meanwhile, the company’s loss per share came in at $1.26, trailing market expectations of a loss per share of $0.11.Opendoor said that it expects Q1 revenue to decrease approximately 10% quarter-over-quarter.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around OPEN trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have risen 221% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Kaz Nejatian, CEO, Opendoor, speaks onstage during "At the Builder's Table: Building Successful Businesses" panel in Atlanta, Georgia.

Exclusive: Opendoor CEO Reveals Company’s Own Mortgage Product Is In Beta Phase, Criticizes Fed On Interest Rates

OPEN’s CEO Kaz Nejatian said that truflation is a much better measure of inflation and no one who invests their own money looks at BLS data. 

<ul class="summary-bullets"><li>As part of the deal, Accord will utilize more than 100 sales, medical, and marketing professionals to drive the adoption of Anktiva in the U.K., the European Union, Norway, Iceland, and Liechtenstein.</li><li>ImmunityBio founder Patrick Soon-Shiong said the company’s goal is to expand access to Anktiva by completing a randomized trial in patients with BCG-naïve disease.</li><li>The company announced on Wednesday that it has received EU approval for the use of Anktiva in combination with BCG.</li></ul>ImmunityBio Inc. (IBRX) on Thursday announced a partnership with Accord Healthcare to expand access to Anktiva across 30 countries.The company also announced the establishment of an Irish subsidiary in Dublin to support its distribution and commercialization strategy across Europe.<a href="https://stocktwits.com/symbol/IBRX">ImmunityBio shares</a> were down around 9% in Thursday’s opening trade after surging about 42% on Wednesday. Retail sentiment on Stocktwits around the company trended in the ‘bullish’ territory at the time of writing.<h2 class="st-heading-2">ImmunityBio’s Partnership With Accord</h2>ImmunityBio said its partnership with Accord will help it unlock the full commercial potential of Anktiva in Europe.“Our partnership with Accord marks a significant step in our European growth strategy and our mission to redefine cancer care,” said ImmunityBio CEO Richard Adcock.As part of the deal, Accord will utilize more than 100 sales, medical, and marketing professionals to drive the adoption of Anktiva in the United Kingdom, the European Union, Norway, Iceland, and Liechtenstein.ImmunityBio founder Patrick Soon-Shiong said that the company’s goal is to broaden access to Anktiva by completing the randomized trial in patients with BCG-naïve disease, which refers to non-muscle invasive bladder cancer (NMIBC) in patients who have never received Bacillus Calmette-Guérin (BCG) immunotherapy, or those who experience recurrence more than 24 months after completing prior BCG treatment.<h2 class="st-heading-2">ImmunityBio Receives EU Approval</h2>ImmunityBio&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibrx-gains-on-fresh-approval-for-bladder-cancer-drug-in-eu/cZR0UjXR4vV">announced</a> on Wednesday that it has received EU approval for the use of Anktiva in combination with BCG.This comes days after the Saudi Food and Drug Authority (SFDA)&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/how-high-can-ibrx-stock-go-after-saudi-fda-bladder-cancer-nod/cZR0i4ZR4H1">encouraged</a> the company to submit a regulatory filing for its recombinant BCG therapy to help address treatment shortages and expand access.The company also said that it is in talks with Saudi regulators to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibrx-stock-jumps-pre-market-saudi-update-bcg/cZRWmDaR4uh">broaden</a> Anktiva’s use in combination with checkpoint inhibitors across multiple tumor types. Last month, the SFDA granted ImmunityBio accelerated approval for Anktiva in the treatment of metastatic non-small cell lung cancer and for BCG-unresponsive bladder cancer.<a href="https://stocktwits.com/symbol/IBRX">IBRX stock</a> is up 306% year-to-date and 106% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-jobless-claims-report-february-14-2026-week/cZRj6UmR4DT">Jobless Claims Drop By Most In Over Two Months, Coming In Below Expectations</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries

The company also announced the establishment of an Irish subsidiary in Dublin to support its distribution and commercialization strategy across Europe.

<ul class="summary-bullets"><li>Lemonade noted that while its growth drivers are increasingly diversified, insurance for pets and cars remains in the driver’s seat.</li><li>The company’s pet insurance segment delivered an IFP growth in the mid-50s for the second consecutive year, accounting for a total of $439 million during the year.</li><li>The car insurance segment also delivered a notable IFP growth of 53% during the year, accounting for $187 million of Lemonade’s total In Force Premiums.</li></ul>Lemonade Inc. (LMND) shares soared nearly 18% in Thursday’s pre-market trade after the company reported its ninth consecutive quarter of In Force Premium (IFP) growth acceleration.“The strength of Q4's results reflects the compounding nature of our model. Faster growth expands our data advantage, which sharpens our AI-powered segmentation and pricing models,” Lemonade said, while noting that IFP grew 31% year-on-year to $1.24 billion in Q4.Lemonade’s fourth-quarter (Q4) results also beat Wall Street estimates. The company reported a loss of $0.29 per share during the quarter on revenue of $228 million, while Wall Street analysts expected a loss of $0.39 per share on revenue of $218 million, according to Stocktwits data.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/LMND">Lemonade</a> trended in the ‘bullish’ territory at the time of writing, with message volumes at ‘high’ levels.<h2 class="st-heading-2">Pets And Cars Drive Lemonade’s Growth</h2>Lemonade noted that while its growth drivers are increasingly diversified, insurance for pets and cars remains in the driver’s seat.Lemonade’s pet insurance segment delivered an IFP growth in the mid-50s for the second consecutive year, accounting for a total of $439 million during the year. “Our share of new pet insurance business continued to expand: Lemonade now has the fastest-growing share of Google search volume among U.S. pet insurance companies,” the company said.The car insurance segment also delivered a notable IFP growth of 53% during the year, accounting for $187 million of the company’s total In Force Premiums. Lemonade expects 2026 to be the year of a broader breakout for car insurance.The segment also showed a significant underwriting improvement, with loss ratio improving meaningfully as pricing segmentation, telematics-driven loss prediction, claims efficiency, and accuracy all advanced in parallel, Lemonade added.<h2 class="st-heading-2">AI Drives Down Lemonade’s Cost Of Claims</h2>The New York-headquartered insurance company also noted that artificial intelligence has driven down its cost of claims.Lemonade Pets, for instance, saw a continued decline in the cost of claims during 2025. The company said that while each pet insurance claim cost $44 in 2021, it is now down to $14.“Our 2025 result of $14 represents a level we believe to be industry-leading and is a clear testament to the growing impact of AI across claims and operations,” Lemonade said.<h2 class="st-heading-2">2026 Outlook</h2>For fiscal year 2026, Lemonade sees revenue in the $1.187 billion to $1.192 billion range, compared to a consensus estimate of $1.16 billion. In the first quarter (Q1), Lemonade expects revenue to be between $246 million and $251 million, compared to an estimated $241.57 million, according to TheFly.“We will continue to deploy our LTV AI across channels, products, and geographies to drive rapid gross profit growth, while using AI to drive operating leverage and reach Adjusted EBITDA profitability,” the company added.<a href="https://stocktwits.com/symbol/LMND">LMND stock</a> is down 8% year-to-date, but up 71% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/iaea-chief-warns-iran-not-much-time-left-as-trump-warns-of-consequences/cZRjHiQR4wt">IAEA Chief Warns Iran 'Not Much Time' Left For Nuclear Deal As Trump Signals Consequences: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

​​In this photo illustration, the Lemonade logo is displayed on a smartphone screen on Feb. 23, 2025, in Chongqing, China. (Photo by Cheng Xin/Getty Images)

LMND Stock Soars Pre-Market: Lemonade Extends Premium Growth Streak To Ninth Consecutive Quarter

Lemonade reported a 31% year-on-year growth in In Force Premium to $1.24 billion in the fourth quarter.

<ul class="summary-bullets"><li>The transaction is expected to close in mid-2026, the company said.</li><li>Of the $1.15 billion, about $240 million in cash will be paid at closing of the transaction.</li><li>Eucalyptus CEO Tim Doyle will join Hims &amp; Hers as senior vice president of International.</li></ul>Hims &amp; Hers Health, Inc. (HIMS) announced on Thursday that it has signed a definitive agreement to acquire Eucalyptus in a deal valued at up to $1.15 billion.<a href="https://stocktwits.com/symbol/HIMS">HIMS shares</a> pared most of their gains after the opening bell and were trading 0.5% higher at the time of writing&nbsp;<h2 class="st-heading-2">Eucalyptus Acquisition Marks Expansion Into Australia and Japan</h2>The transaction, expected to close in mid-2026, will strengthen the company’s ability to deliver personalized digital healthcare internationally, Hims &amp; Hers said.Upon completion, Hims &amp; Hers plans to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. Eucalyptus CEO Tim Doyle will join Hims &amp; Hers as senior vice president (SVP) of International, and Eucalyptus’ brands will gradually transition to the Hims &amp; Hers platform.“We've shown the difference that makes in the US, and the logical next step is working with more international experts to make that difference abroad,” said Andrew Dudum, founder and CEO of Hims &amp; Hers.&nbsp;<h2 class="st-heading-2">$240 Million To Be Paid At Transaction’s Close</h2>Out of the $1.15 billion, about $240 million in cash will be paid at closing, with the remaining consideration comprising guaranteed deferred payments over 18 months and additional earnouts tied to financial targets through early 2029.&nbsp;Hims &amp; Hers said it can pay most deferred and earnout amounts in cash or stock and expects to fund the deal primarily with existing cash and future U.S. operating cash flow.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘neutral’ from ‘bearish’ a day earlier.&nbsp;One user expects margins and cash flow to “plummet”.<stembedurl>https://stocktwits.com/BreakingBS/message/645350664</stembedurl>Another user sees consolidation amid fading selling pressure.<stembedurl>https://stocktwits.com/Businesspro/message/645341441</stembedurl>Year-to-date, the stock has declined more than 50%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Hims & Hers Health in front of a screen showing the company's stock market chart. (Photo illustration by Cheng Xin/Getty Images)

Hims & Hers Health Makes Australia, Japan Foray With $1.15 Billion Eucalyptus Acquisition

The company said the acquisition will also deepen its presence in the UK, Germany, and Canada..

The company said the acquisition will also deepen its presence in the UK, Germany, and Canada.

<ul class="summary-bullets"><li>QXO stated that the Kodiak acquisition is expected to be highly accretive to the company’s 2026 earnings, anticipating its total addressable market to expand to more than $200 billion.</li><li>The company added that Kodiak generated $2.4 billion in revenues in 2025, distributing lumber, trusses, windows, and doors, among other building products.</li><li>QXO added that Kodiak is a business leader in most of the geographies it operates in, with particular concentration in the Sun Belt and Mountain states.</li></ul>QXO Inc. (QXO) shares soared nearly 12% in Wednesday’s pre-market trade after the company announced that it has entered into a definitive agreement to acquire Kodiak Building Partners in a $2.25 billion deal.QXO said it will pay $2 billion in cash and 13.2 million shares, with the transaction expected to close in the second quarter of 2026, subject to regulatory approvals.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/QXO">QXO</a> trended in the ‘bearish’ territory at the time of writing, with message volumes at ‘high’ levels. The QXO stock was among the top ten trending tickers on the platform.<h2 class="st-heading-2">Why Is QXO Acquiring Kodiak?</h2>QXO stated that the Kodiak acquisition is expected to be highly accretive to the company’s 2026 earnings, anticipating its total addressable market to expand to more than $200 billion.The company added that Kodiak generated $2.4 billion in revenues in 2025, distributing lumber, trusses, windows, and doors, among other building products. QXO added that Kodiak is a business leader in most of the geographies it operates in, with particular concentration in the Sun Belt and Mountain states.“The acquisition of Kodiak is highly complementary to our existing business. We’ll be able to deliver more value to customers across our combined base by cross-selling products and support services, and with a greater presence in key markets,” said QXO CEO Brad Jacobs.The company expects the integration of Kodiak and QXO’s offerings to help increase its market share with large homebuilders. It added that Florida and Texas accounted for nearly 40% of Kodiak’s 2025 revenues and that these two states have seen building market growth outpace national growth over the last decade.<h2 class="st-heading-2">What Does QXO Do?</h2>QXO is a Greenwich, Connecticut-based distributor of building products and a technology service provider. The company has a network of over 8,000 professionals across North America.On the other hand, Kodiak has about 5,500 employees across 110 locations in 26 states. The company currently serves over 10,000 customers.<a href="https://stocktwits.com/symbol/QXO">QXO stock</a> is up 20% year-to-date and 72% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/el-paso-airport-faa-halts-all-flights-for-10-days-starting-february-11/cZb6aUyR4q1">FAA Halts All Flights At El Paso Airport In Texas Citing ‘Special Security Reasons’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the QXO logo is seen displayed on a smartphone screen. 

QXO Stock Is Soaring Pre-Market Today — What Is Fueling The Surge?

The company will pay $2 billion in cash and 13.2 million shares, with QXO expecting the Kodiak transaction to close in the second quarter of 2026.

<ul class="summary-bullets"><li>Amazon’s investment in BETA is its second-largest stock position in the fourth-quarter.</li><li>Amazon acquired more than 11.75 million shares in the company.&nbsp;</li><li>BETA Technologies is a Vermont-based aerospace company that develops all-electric aircraft.</li></ul>Amazon.com (AMZN) announced on Tuesday that it has taken a 5.3% stake in BETA Technologies Inc. (BETA), a Vermont-based aerospace company that develops all-electric aircraft.In a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0001018724/79bd6fb3-9145-44ad-814c-032f345f07e2.pdf">filing</a> with the U.S. Securities and Exchange Commission, Amazon disclosed a 5.3% stake in Beta Technologies as of Dec. 2025. Amazon acquired more than 11.75 million shares in the transaction, worth $331.6 million.Shares of BETA rallied nearly 20% in Tuesday’s after-market hours following Amazon’s disclosure. The filing with the SEC does not allow for activism.Amazon’s investment in BETA is its second-largest stock position in the fourth-quarter (Q4).<h2 class="st-heading-2">What Is BETA?</h2>BETA Technologies designs, manufactures and sells high-performance electric aircraft, advanced electric propulsion systems, components and charging systems across the world.BETA raised $1.01 billion in its U.S. initial public offering in November 2025, selling 29.9 million shares at $34 each, above its indicated range of $27 to $33.The company’s aircraft platform, ALIA, provides two variants — a conventional fixed-wing electric airplane (eCTOL) and an electric vertical takeoff and landing aircraft (eVTOL).BETA is also deploying its charging infrastructure across more than 50 sites online in the U.S. and Canada and has more than 800 aircraft in backlogs. The company’s aircraft have hit more than 119,000 nautical miles at the time of writing.BETA’s aircraft have been deployed by the U.S. military in training missions and also used by the Federal Aviation Administration.<h2 class="st-heading-2">Amazon’s Positions</h2>As of Dec. 31, 2025, Amazon sold its positions in Vital Farms (VITL), SmartRent (SMRT), and Owlet (OWLT).Meanwhile, Amazon's top stock holdings in Q4 were Rivian (RIVN), BETA Technologies, Astera Labs (ALAB), Marvell (MRVL) and Nautilus Biotechnology (NAUT).<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around BETA shares jumped from ‘bullish’ to ‘extremely bullish’ over the past 24 hours amid ‘extremely high’ message volumes.One user noted that Amazon was buying BETA stock at 52-week lows, and said it was a good buy.<stembedurl>https://stocktwits.com/hockeysniper/message/644614686</stembedurl>&nbsp;<a href="https://stocktwits.com/symbol/BETA">Shares of BETA</a> are down over 53% since listing in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-evgn-shares-drop-today/cZbU1PBR4pm">Why Did EVGN Shares Drop More Than 14% Today?</a>

In this photo illustration, the Beta Technologies logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Amazon Announces 5.3% Stake In Beta Technologies, Sending Stock Soaring After-Hours

In a filing with the U.S. Securities and Exchange Commission, Amazon disclosed a 5.3% stake in Beta Technologies, worth $331.58 million.

The Rivian logo is on display during the 2025 Los Angeles Auto Show at the Los Angeles Convention Center on November 23, 2025 in Los Angeles, California

Rivian Stock Gains As EV Maker Gears To Share Pricing Details On Its Upcoming Mass-Market SUV

The company said in a post on social media platform X that it will share details pertaining to the vehicle’s pricing, options, and more on March 12.

Vanguard Group, Inc. - Vanguard Small Cap Growth ETF

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Current Price	$319.97
Prev Close	$315.84
Open	$315.22
Dividend Yield	N/A
50-Day Moving Average	$314.57
Beta	N/A
Avg. Volume	347,056.90
PE Ratio	N/A

52-Week High	$329.04
52-Week Low	$214.77
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

VBK
Vanguard Small Cap Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VBK News

VBKVanguard Small Cap Growth ETF